Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

Previous alopecia areata treatments do not affect the long-term effectiveness of ritlecitinib.

Baricitinib may effectively treat nail changes in alopecia areata.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

Adding dupilumab led to almost complete hair regrowth in a patient with alopecia areata who only partially responded to baricitinib.

Reducing the dose of Baricitinib to 2mg still helped over half of the patients with severe scalp alopecia maintain their hair regrowth after two years.

Tofacitinib helped regrow hair in a woman with alopecia areata.

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

Bicalutamide effectively treats prostate cancer but needs careful monitoring for side effects.

Arsenic trioxide effectively treats relapsed acute promyelocytic leukemia with manageable side effects.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Tofacitinib treatment for hair loss may worsen acne.

Baricitinib helps alopecia areata and may improve psoriasis, but its effect on psoriatic arthritis is unclear.

Continued ritlecitinib treatment helps sustain hair regrowth in alopecia areata patients.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

A patient developed nerve problems as a side effect of a hair loss treatment called tofacitinib.

Deuruxolitinib significantly helps regrow scalp hair in adults with moderate to severe alopecia areata.

Tofacitinib may help hair regrowth in alopecia areata, but more research is needed.

Topical ruxolitinib may help some skin conditions but needs more research for alopecia areata.

Tofacitinib can cause skin eruptions similar to palmoplantar pustulosis.

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

A bull with a gene mutation was asymptomatic, synthetic retinoids cause hair loss, and new therapeutic targets were identified for skin diseases.

Baricitinib can cause excessive hair growth.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.